2009
DOI: 10.1152/ajpheart.00132.2009
|View full text |Cite
|
Sign up to set email alerts
|

Nonmuscle myosin is regulated during smooth muscle contraction

Abstract: The participation of nonmuscle myosin in force maintenance is controversial. Furthermore, its regulation is difficult to examine in a cellular context, as the light chains of smooth muscle and nonmuscle myosin comigrate under native and denaturing electrophoresis techniques. Therefore, the regulatory light chains of smooth muscle myosin (SM-RLC) and nonmuscle myosin (NM-RLC) were purified, and these proteins were resolved by isoelectric focusing. Using this method, intact mouse aortic smooth muscle homogenates… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
88
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(100 citation statements)
references
References 50 publications
11
88
0
1
Order By: Relevance
“…Due to the small amount of force for residual contraction and atypical waveform of contraction, we could not determine whether the small contraction was more sensitive to blebbistatin, thereby indicating a primary contribution of nonmuscle myosin II. However, we expect that MLCK also catalyzes non-muscle myosin phosphorylation if it contributes to force development in tonic contraction (42). Blebbistatin is an effective inhibitor of smooth muscle actomyosin and smooth muscle contraction from mammals and chicken arteries, whereas it is not as effective for inhibiting gizzard smooth muscle contractions, consistent with the original report that blebbistatin was not effective in inhibiting avian gizzard actomyosin ATPase activity (34).…”
Section: Ca 2ϩsupporting
confidence: 76%
“…Due to the small amount of force for residual contraction and atypical waveform of contraction, we could not determine whether the small contraction was more sensitive to blebbistatin, thereby indicating a primary contribution of nonmuscle myosin II. However, we expect that MLCK also catalyzes non-muscle myosin phosphorylation if it contributes to force development in tonic contraction (42). Blebbistatin is an effective inhibitor of smooth muscle actomyosin and smooth muscle contraction from mammals and chicken arteries, whereas it is not as effective for inhibiting gizzard smooth muscle contractions, consistent with the original report that blebbistatin was not effective in inhibiting avian gizzard actomyosin ATPase activity (34).…”
Section: Ca 2ϩsupporting
confidence: 76%
“…If so, our results would suggest that the RhoA-mediated phosphorylation of non-muscle myosin II light chain would be critical for excitation-contraction coupling and smooth muscle contraction. Non-muscle myosin II is expressed in cultured human airway smooth muscle cells (53) and has also been documented in vascular smooth muscle tissues (54).…”
Section: Discussionmentioning
confidence: 99%
“…Of the three nonmuscle myosin II isoforms, myosin IIB has the highest duty ratio (34) and the highest affinity for ADP (35), suggesting that it may be tuned for prolonged force production and minimal energy consumption. Previous work has shown that myosin IIB contributes to force maintenance in aortic smooth muscle (36). The myoepithelial layer of mammary gland tissue is responsible for the contractile events during milk secretion (37) and has been suggested to be critical for proper branching architecture (38), an essential component of mammary gland development.…”
Section: Discussionmentioning
confidence: 99%